Preferred Label : raynaud phenomenon;

UMLS semantic type : T047 - Disease or Syndrome;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les
2023
United Kingdom
review of literature
french abstract
Ratio
secondary raynaud's phenomenon
Increased
Current Reformed Smoker, Years Unknown
increased vascular flow
risks and benefits
Fear Score 5
Medication
Placebo
raynaud disease
What Month is it
Loss of Chromosome 5
Intensity and Distress 5
drug, nos
Flow
Extremities
Clinical Status Ordinal Scale Outcome 5
extremities
Version
research report
ECOG Performance Status 5
anthelmintics
Severity of Symptom Score 5
No Flow
Thought Score 5
raynaud phenomenon
Death Related to Adverse Event
Agreement Score 5
Illness Intrusiveness Rating 5
Raynaud Phenomenon
Gleason Grade Group 5
risk assessment
placebos
Phase V Trial
Regulatory Report
Phosphodiesterase Inhibitor
Neck Pain Score 5
phosphodiesterase 5 inhibitors
Upset Score 5
albumin/globulin ratio
Increase
Flux
GDC Therapeutic Agent Terminology

---
https://www.cbip.be/fr/articles/3752?folia=3740
2022
false
false
false
Belgium
French
journal article
raynaud phenomenon
migraine disorders
erenumab
fremanezumab
galcanezumab
calcitonin gene-related peptide
cohort studies
Calcitonin gene-related peptide (CGRP) antagonists
disease progression

---
https://www.medg.fr/phenomene-de-raynaud
2021
France
teaching material
scientific and technical information
secondary raynaud's phenomenon
raynaud disease
raynaud phenomenon

---
https://sides.uness.fr/corpus/Dermatologie:Acrosyndromes._Ph%C3%A9nom%C3%A8ne_de_Raynaud,_%C3%A9rythermalgie,_acrocyanose,_engelures,_isch%C3%A9mie_digitale
2021
France
educational course
digitalis, nos
Acrocyanosis
Chilblain
chilblains
digitalis
erythromelalgia
ischemia
dermatology
Dermatology
acrocyanosis
chilblains
ischemia, nos
Dermatology
raynaud phenomenon
secondary raynaud's phenomenon
erythromelalgia
raynaud disease
Ischemia

---
http://www.cochrane.org/fr/CD000467/inhibiteurs-des-canaux-calciques-pour-le-phenomene-de-raynaud-primitif-et-secondaire
2017
false
false
false
France
United Kingdom
French
french abstract
calcium channel blockers
review of literature
treatment outcome
risk assessment
raynaud phenomenon
placebos
Evidence-Based medicine
calcium channel blockers
calcium channel blockers
randomized controlled trials as topic
Isolated primary Raynaud's phenomenon (disorder)
Secondary Raynaud's phenomenon (finding)
severity of illness index
raynaud disease

---
https://rmlg.uliege.be/article/2364
2012
Belgium
teaching material
journal article
raynaud disease
secondary raynaud's phenomenon
students
diagnosis
student, nos
raynaud phenomenon

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.